Mainz Biomed BV (MYNZ) — Financial Flexibility Index
Mainz Biomed BV (MYNZ) has a Financial Flexibility Index of -0.95x as of December 2025. Free cash flow of $-4.46 Million (operating CF $-4.46 Million minus capex $93.00) represents -1% of total liabilities ($4.69 Million). Also explore Mainz Biomed BV (MYNZ) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mainz Biomed BV Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Mainz Biomed BV across 7 annual periods. Check strategic asset allocation of Mainz Biomed BV to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Mainz Biomed BV (2019–2025)
Year-by-year free cash flow to debt coverage for Mainz Biomed BV. For the full company profile including market capitalisation, see market cap of Mainz Biomed BV.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.34x | $-10.98 Million | $-10.98 Million | $4.69 Million | ▼ -0.1% |
| 2024 | -2.34x | $-16.84 Million | $-17.09 Million | $7.19 Million | ▼ -42.0% |
| 2023 | -1.65x | $-20.04 Million | $-21.94 Million | $12.16 Million | ▲ +28.2% |
| 2022 | -2.30x | $-14.11 Million | $-14.77 Million | $6.14 Million | ▼ -163.8% |
| 2021 | -0.87x | $-3.20 Million | $-3.22 Million | $3.68 Million | ▼ -547.7% |
| 2020 | -0.13x | $-459.05K | $-468.74K | $3.41 Million | ▲ +11.9% |
| 2019 | -0.15x | $-406.81K | $-416.50K | $2.67 Million | — |